CYP2C19*1 and CYP2C19*2 Polymorphism in Turkish Patients Being Diagnosed with Stable Coronary Artery Disease and Using Clopidogrel
Objective:The CYP2C19*1 has an entirely normal activity allele whose clopidogrel metabolism is normal. CYP2C19*2 called as non-functional alleles. In this study, we aimed to establish the CYP2C19*1 and CYP2C19*2 genotype frequencies both in Turkish patients with coronary artery disease (CAD), who us...
Main Authors: | Ramazan Sabırlı, Aylin Köseler, Atakan Yılmaz, İsmail Doğu Kılıç |
---|---|
Format: | Article |
Language: | English |
Published: |
Galenos Yayinevi
2021-03-01
|
Series: | Bagcilar Medical Bulletin |
Subjects: | |
Online Access: |
http://behmedicalbulletin.org/archives/archive-detail/article-preview/cyp2c191-and-cyp2c192-polymorphism-in-turkish-pati/42603
|
Similar Items
-
Prevalence of CYP2C19*2 and CYP2C19*3 Allelic Variants and Clopidogrel Use in Patients with Cardiovascular Disease in Trinidad & Tobago
by: Daniele Jones, et al.
Published: (2024-01-01) -
CYP2C19 genetic variation and individualized clopidogrel prescription in a cardiology clinic
by: Seyed abbas Mirabbasi, et al.
Published: (2017-07-01) -
Association with CYP2C19 polymorphisms and Clopidogrel in treatment of elderly stroke patients
by: Changqing Li, et al.
Published: (2021-03-01) -
Influence of CYP2C19*2 gene variant on therapeutic response during clopidogrel treatment in patients with carotid artery stenosis
by: Bačković Dragana, et al.
Published: (2016-01-01) -
A synergic effect between CYP2C19*2, CYP2C19*3 loss-of-function and CYP2C19*17 gain-of-function alleles is associated with Clopidogrel resistance among Moroccan Acute Coronary Syndromes patients
by: Hind Hassani Idrissi, et al.
Published: (2018-01-01)